We are live on ! Find out more
BBP icon

Virtus Biotech ETF
BBP

18 hedge funds and large institutions have $6.16M invested in Virtus Biotech ETF in 2017 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 5 increasing their positions, 2 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

500% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 1

150% more repeat investments, than reductions

Existing positions increased: 5 | Existing positions reduced: 2

29% more funds holding

Funds holding: 14 → 18 (+4)

18% more capital invested

Capital invested by funds: $5.22M → $6.16M (+$946K)

0.45% more ownership

Funds ownership: 16.78% → 17.22% (+0.45%)

Holders
18
Holders Change
+4
Holders Change %
+28.57%
% of All Funds
0.45%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
5
Reduced
2
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$456K
2
LPL Financial
LPL Financial
California
+$221K
3
Stifel Financial
Stifel Financial
Missouri
+$213K
4
Royal Bank of Canada
Royal Bank of Canada
Ontario, Canada
+$117K
5
JP Morgan Chase
JP Morgan Chase
New York
+$82.6K

Top Sellers

Rank Fund Capital Flow
1
VKH
Virtu KCG Holdings
New York
-$596K
2
VFPI
Vantage Financial Partners (Illinois)
Illinois
-$284K
3
UBS Group
UBS Group
Switzerland
-$55.1K
Name Holding Trade Value Shares
Change 		Change in
Stake
Royal Bank of Canada
1
Royal Bank of Canada
Ontario, Canada
$3.57M +$117K +3,187 +3%
LPL Financial
2
LPL Financial
California
$1.05M +$221K +6,047 +27%
Citadel Advisors
3
Citadel Advisors
Florida
$470K +$456K +12,453 New
Stifel Financial
4
Stifel Financial
Missouri
$223K +$213K +5,825 New
VKH
5
Virtu KCG Holdings
New York
$217K -$596K -16,263 -74%
FDCDDQ
6
Federation des caisses Desjardins du Quebec
Quebec, Canada
$142K +$137K +3,750 New
AG
7
Advisor Group
Arizona
$116K +$81.2K +2,216 +263%
LTFS
8
Ladenburg Thalmann Financial Services
Florida
$107K – – –
UBS Group
9
UBS Group
Switzerland
$90K -$55.1K -1,505 -39%
JP Morgan Chase
10
JP Morgan Chase
New York
$85K +$82.6K +2,256 New
FWM
11
Focused Wealth Management
New York
$38K – – –
IA
12
IFP Advisors
Florida
$19K +$7.32K +200 +67%
CFA
13
Carroll Financial Associates
North Carolina
$9K – – –
Creative Planning
14
Creative Planning
Kansas
$8K – – –
Fifth Third Bancorp
15
Fifth Third Bancorp
Ohio
$6K – – –
Morgan Stanley
16
Morgan Stanley
New York
$5K +$1.28K +35 +35%
YWP
17
YorkBridge Wealth Partners
New York
$5K +$4.76K +130 New
TRCT
18
Tower Research Capital (TRC)
New York
$1K +$1.28K +35 New
VFPI
19
Vantage Financial Partners (Illinois)
Illinois
– -$284K -8,700 Closed

BBP Hedge Fund Activity: Q1 2017 in Review

18 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Virtus Biotech ETF (BBP) for Q1 2017, worth a combined $6.16M — up 18% from $5.22M a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new BBP positions and 1 closed out — a net gain of 5 holders — while 5 added to existing stakes and 2 trimmed.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $456K. The largest seller was Virtu KCG Holdings, cutting an estimated $596K.

  • 18 institutional investors held Virtus Biotech ETF (BBP) as of Q1 2017, up from 14 in Q4 2016.
  • Funds reported $6.16M of Virtus Biotech ETF stock for Q1 2017, up 18% quarter-over-quarter.
  • 6 funds opened new Virtus Biotech ETF positions in Q1 2017 and 1 closed out, a net change of +5 holders.
  • The largest Virtus Biotech ETF buyer in Q1 2017 was Citadel Advisors, an estimated $456K added.
  • The largest Virtus Biotech ETF seller in Q1 2017 was Virtu KCG Holdings, an estimated $596K sold.

Based on aggregated 13F filings for Q1 2017.